The Treatments Bailey O'Brien Used at CHIPSA Hospital To Beat Stage 4 Cancer
BY EDWARD CRUZ, MAY 27, 2015 11:00 AM
Founded in 1979 CHIPSA hospital has been focusing on rebuilding and regenerating immune function for 37 years.
Traditional cancer treatments, like chemotherapy focus on breaking down the body and the cancer through the use of harmful drugs and radiation. They aggressively seek to "kill" the cancer, but in turn, can end up killing your body as well. Unfortunately the end result can be life-long havoc on your immune system, forever altered DNA...and in many cases the cancer comes back.
During her stay at CHIPSA hospital Bailey O'brien's healing from cancer began with an integrative approach of treatments that focused instead on strengthening her immune system and "teaching" her own body to fight the cancer itself.
Listed below are treatments that Bailey used:
Coley's Toxins
Coley Vaccine (Mixed Bacterial Vaccine), also known as Coley's Toxins or Coley Fluid (CF) is a treatment originally developed by Memorial Hospital surgeon, Dr. William Coley in 1891 for the treatment of Cancer.
Frustrated when "conventional" treatments had failed him, Dr. Coley sought out other therapies after one his patients, Bessie Dashiell died form sarcoma. He had followed strict protocol and amputated her arm, expecting that to stop the cancer. Instead the cancer came back with a vengeance and Bessie died a very painful death.
The Search For A Cure:
Devastated by what had transpired, Dr. Coley scoured Memorial hospital's records searching for anybody that had survived sarcoma. At last he came across a "one" patient who had beat the cancer. Ironically this patient had contracted an Erysipelas infection, a type of Streptococcus bacteria. Dr. Coley traveled to Manhattan to meet this patient and to his surprise the patient was still alive and well, 7 years cancer free. In fact, the patient lived for 27 years more and died of a heart attack. At the time of death he was cancer free!
Dr Coley surmised that if an accidental infection cured the cancer, that an intentional infection would produce similar results. He believed that the infection triggered an immune response that allowed the body attack the cancer itself.
How It Works:
Coley’s Mixed Vaccine is comprised of a sterile(dead) mixture of gram-positive Streptococcus pyogenes and gram-negative Serratia marcescens bacteria. By introducing the killed bacteria into the body, Dr. Coley could mimic an immune response without the risk of infection.
Since cancer cells were formed undetected, the goal is to “unlock” the body’s immune system so that it can identify and kill the cancer cells.
- Coley Vaccine therapy is administered about 2-3 times per week at a dose which achieves a body temperature of between 39.5 °C to 41 °C (approximately 103 °C to 106 °F), while being monitored by qualified medical staff.
- The exact number of treatments per week may vary depending on each individual patient and other circumstances.
- Patients generally receive one infusion per day.
- About 5-6 hours of treatment are required for each treatment day.
- Vital signs (blood pressure, heart rate, respiratory rate, temperature) are constantly monitored by professional and experienced medical staff.
- Coley Vaccine has a very long and safe history of use.
- Generally patients experience improved well being after each treatment.
- This treatment is ideally used in conjunction with other immunotherapies, such as Gerson Therapy, Dendritic Cells Vaccine, and Issel's Autologous vaccine.
Note: CHIPSA is the only licensed hospital facility treating with the Coley’s Therapy toxins in North America.
Gerson Therapy
Initially Developed by German born Dr. Max Gerson in the 1920's for the treatment of tuberculosis and headaches, Gerson Therapy was applied towards cancer patients in 1928. It is a specific diet-based immunological detoxification and nutrition protocol that is the foundation of the treatments her at CHIPSA.
Gerson therapy focuses on reactivating your body to heal itself through non toxic methods including organic foods, juicing, detoxification and supplements.
Living Legacy: The "Official" Gerson Hospital
After his death, Dr Max Gerson's daughter, Charolette Gerson continued to promote her father's therapy and began working with the the staff at CHIPSA in 1979, treating cancer patients with the Gerson Immuno-nutrition protocols.
For more than 37 years, the medical teams at CHIPSA have been using the Gerson Immuno-nutrition protocols in a hospital treatment environment as part of their integrative therapies and have in fact, contributed to the development and refinement of the Gerson protocols by combining them with other powerful treatments.
Today, Gerson’s+Therapy is the basis upon which all modern immuno-nutrition protocols are founded on.
The Gerson diet-therapy for cancer is an intensive , immunological detoxification and nutrition protocol. Macronutrient manipulation in the context of micronutrient supplementation can help to stimulate immunity and promote tissue integrity. It works closely with the healing forces of nature to stimulate tissue repair and normal growth through the input of more fresh, raw vegetable materials than any other nutritional intervention. Fresh juice, raw fruits and vegetables are the source materials of almost all micronutrients in their pristine organic composition.
The Diet
The diet includes raw and cooked foods in its three daily vegan meals, extraordinary amounts of unaltered foods are consumed as well as the intravenous inclusion of vitamin drips.
Additionally patients can expect anywhere from 12-15 raw juices a day, prepared specific organic fruits and vegetables. These fruits and vegetable are harvested for their enormous quantities of phytochemicals currently under study worldwide for exciting anticancer and health promoting properties, "super charging" the patient's immune system.
Oncological diet therapy is a medical specialty, not unlike oncological radiotherapy. In many instances diet therapy will be sufficient to cause complete regression of cancer. CHIPSA clinical scientists believe that complementary use of medical specialties will lead to more satisfactory overall outcomes when complementary medical protocols (such as Coley Toxin, Issel protocols and photopheresis) are co-implemented.
Autologous Dendritic Cell Vaccine
Issels Autologous vaccine is one of the most potent forms of immunotherapy that harness the body’s own immune system to fight cancer.
The vaccine is cultured from the patient’s own blood that represents his/her own unique internal bodily environment. The preparation follows procedures that favor the development of antigenic peptides and other immunogenic compounds aiming to enhance the body’s own cancer fighting mechanisms.
What Makes It So Effective?
Clinical research suggests that the Issels Autologous Vaccine works in a very complex way at the levels of cell-mediated and humoral immunity, and stimulates the formation and activation of T-helper cells. It is cultured from the patient’s own blood that represents his/her own unique internal bodily environment. The preparation follows procedures that favor the development of antigenic peptides and other immunogenic compounds aiming to enhance the body’s immune functions.
The vaccine is sterile. Since it is custom prepared from the patient’s own blood, side effects typically associated with other treatments are not experienced. A slight rise in temperature, fatigue, and tenderness in the tumor area are possible for a period of 6 to 48 hours after administration.
Experience has shown us that the effectiveness of the vaccine, or of any vaccine, is enhanced when it is administered within a comprehensive series of integrative immunotherapy and immuno-nutrition protocols.
Dr. Josef Issels, the creator of the Issel's Autologous Vaccine, pursued research on immunological and microbiological aspects of cancer etiology since 1948. He established several research departments in his hospital from its inception in 1951. Already in the early years, Dr. Issels and his co-researchers developed cancer vaccines in laboratories located on the premises.
In 1970, the hospital grew from 85 to 120 patient beds and expanded its extensive research facilities into microbiological, immunological, dental departments, and the hyperthermia department, etc.
Dr. Josef Issels Finishes His Career at CHIPSA
For the last 2 years of his life, Dr. Josef Issels joined the CHIPSA staff as co-principal investigator, bringing more than 40 years of experience serving others using immunotherapy treatments as well as his own autologous cancer vaccines. The mixed bacterial vaccine of Dr. William B. Coley, M.D. is a current standard protocol. CHIPSA Hospital has also added Dr. Evangelos Danopoulos’ well-documented urea/creatine treatment for cancer. The placental extract vaccines developed by Russian immunologist Constantin Govallo, M.D., are also now available as an immunoembryological therapy. These are the latest additions to CHIPSA hospitals standard protocols for treatment of patients with degenerative diseases including cancer.
Laetrile
Laetrile (i.e. amygdalin or Vitamin B17) therapy is one of the most popular and best known alternative cancer treatments. It is very simple to use and is very effective if used in high enough doses and if the product is of high quality and if it is combined with an effective cancer diet and key supplements like the Gerson Immuno-nutrition protocols.
What is Laetrile?
Laetrile is the patented drug made from the natural compound amygdalin, found in the seeds of many fruits, such as apricots, plum and peach pits, apple seeds, and quince, as well as in almonds. Laetrile is also known as Amigdalina B-17 or vitamin B17.
Amygdalin contains glucose, benzaldehyde, and cyanide. Cyanide is believed to be the active cancer-toxic ingredient in Laetrile. However, cyanide is toxic to all cells, so Laetrile’s overall toxicity is a concern which is why it MUST be administered in hospital setting and not at home. At CHIPSA each patient's levels and dosage of Laetrile is custom tailored to their cancer.
In 1924, Laetrile was synthesized from amygdalin and promoted as a cancer treatment. By 1978, it was estimated that more than 70,000 Americans had tried it—despite its being banned in the US since 1963. Most people obtain Laetrile from Tijuana clinics, as the agent is still legal in Mexico.
Dr. Sugiura's Research
Dr. Kanematsu Sugiura, spent most of his career at Memorial Sloan Kettering Cancer Center, authoring more than 250 papers and receiving numerous awards, including the highest honors from the Japan Medical Association for outstanding contributions in cancer research.
While studying Laetrile, which was previously written off as Dr. Sugiura discovered Laetrile to have very positive effects in preventing the spread of malignant lung tumors in laboratory mice.
In control groups, which received only plain saline, the lung tumors spread in 80 to 90 percent of the animals. But in those given Laetrile, the tumors spread in only 10 to 20 percent
Recent studies confirm Dr. Sigiura's findings:
- August 2014: In a new German study, amygdalin dose-dependently reduced growth and proliferation of bladder cancer
- May 2013: Amygdalin inhibits renal fibrosis in chronic kidney disease; researchers conclude it is a “potent antibiotic agent that may have therapeutic potential for patients with fibrotic kidney diseases”
- February 2013: Amygdalin induces apoptosis in human cervical cancer cells; authors conclude it may offer a new therapeutic option for cervical cancer patients
- August 2006: Amygdalin also induces apoptosis in human prostate cancer cells
- February 2003: Amygdalin from Prunus persica seeds (peach pits) shows anti-tumor effects comparable to epigallocatechin gallate in green tea
High Dose Vitamin C
The use of high dose Vitamin C for cancer mitigation has been studied for years. According to the United States government website on Cancer "Laboratory studies have shown that high doses of vitamin C may slow the growth and spread of prostate, pancreatic, liver, colon, and other types of cancer cells"
The National Institute of Health on Vitamin C...
“Many laboratory studies have been done to find out how high-dose vitamin C may cause the death of cancer cells. The anticancer effect of vitamin C in different types of cancer cells involves a chemical reaction that makes hydrogen peroxide, which may kill cancer cells.
The National Cancer Institute says laboratory studies have shown the following:
- Treatment with high-dose vitamin C slowed the growth and spread of prostate, pancreatic, liver, colon, malignant mesothelioma, neuroblastoma, and other types of cancer cells.
- Combining high-dose vitamin C with certain types of chemotherapy may be more effective than chemotherapy alone:
- Ascorbic acid with arsenic trioxide may be more effective in ovarian cancer
- Ascorbic acid with gemcitabine may be more effective in pancreatic cancer
- Ascorbic acid with gemcitabine and epigallocatechin-3-gallate (EGCG) may be more effective in malignant mesothelioma cells.
- Another laboratory study suggested that combining high-dose vitamin C with radiation therapy killed more glioblastoma multiforme cells than radiation therapy alone.”
The Cancer Center at CHIPSA Research Hospital in Mexico uses high dose IV Vitamin C in conjunction with their other innovative treatments such as Coley’s Toxins, Gerson Therapy, Isssel's Autologous Vaccine and other immunotherapies to maximize effectiveness
What We Know Now About Cancer Treatments
We are not in any way, shape or form, stating that there is a definite cure for cancer. It’s very common to see alternative practitioners making claims that one substance or "thing" is an all out cure.
We we do know, however, that CHIPSA hospital has been treating many patients like Bailey for close to 37 years. There is no 100% cure. Cancer is very complex and always evolving . We also know that CHIPSA has had great success treating many patients that were sent home to "die" in their home country because conventional medicine failed them.
Free